Omics Biosciences Private Limited
About Omics Biosciences Private Limited
Data last updated:
Omics Biosciences Private Limited is a private limited company based in Eluru, Andhra Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 02 February 2022.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24290AP2022PTC120703.
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹55 Lakh. It is led by directors Sravan Kumar Kotha and Venkata Subbaraju Bhupathiraju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – 502 Vvn Residency 40 – A Ashok Nagar, Eluru, Andhra Pradesh, India – 534002.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.59 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.33 Lakh (net margin 1.5%) and EBITDA of ₹3.12 Lakh (EBITDA margin 2%).
As per MCA filings, the company has open charges of ₹2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Omics Biosciences Private Limited's registered office is in Eluru, Andhra Pradesh.
- Registered AddressFlat No – 502 Vvn Residency 40 – A Ashok Nagar, Eluru, Andhra Pradesh, India – 534002
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Omics Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Omics Biosciences Private Limited, buy the company report.
Financials of Omics Biosciences Private Limited
FY 2025 filings availableOmics Biosciences Private Limited reported revenue of ₹1.59 Cr (up 211% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 211% in the latest year. EBITDA rose 522% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.12 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.33 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2% | |||
| Net Profit Margin | 1.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Omics Biosciences Private Limited, buy the company report.
Board of directors of Omics Biosciences Private Limited
Omics Biosciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sravan Kumar Kotha | Director | 29 Jan 2024 | 2 Years 8 Months | Current |
| Venkata Subbaraju Bhupathiraju | Director | 29 Jan 2024 | 2 Years 8 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Apr 2025 | 101092313 | Others | ₹2 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Omics Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Omics Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Omics Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Omics Biosciences Private Limited has 4 board changes on record since 2024: 2 appointments and 2 cessations. The latest: Pruthvi Vankineni Krishna ceased to be Director on 29 Jan 2024.
Frequently asked questions
Omics Biosciences is an active private limited company based in Eluru, Andhra Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 02 February 2022 (4+ years old) and is registered under CIN U24290AP2022PTC120703.
Omics Biosciences has 2 current directors:
- Sravan Kumar Kotha - Director
- Venkata Subbaraju Bhupathiraju - Director
The latest financial statements of Omics Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Omics Biosciences is U24290AP2022PTC120703. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Omics Biosciences was incorporated on 02 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Vijayawada.
Pruthvi Vankineni Krishna ceased to be Director on 29 Jan 2024. Siva Bhaskara Paturi Naren ceased to be Director on 29 Jan 2024. Sravan Kumar Kotha was appointed as Director on 29 Jan 2024. Omics Biosciences has 4 board changes on record in total.
The registered office of Omics Biosciences is at Flat No – 502 Vvn Residency 40 – A Ashok Nagar, Eluru, Andhra Pradesh, India – 534002.
Omics Biosciences operates in the chemicals industry, in the manufacturing segment.
Omics Biosciences has open charges of ₹2 Cr and no satisfied charges on record as per latest MCA filings.
The compliance status of Omics Biosciences is compliant as of 06 September 2026. The company is actively filing with the Registrar of Companies.